Bhattacharjee Arnab, Reuter Stefanie, Trojnár Eszter, Kolodziejczyk Robert, Seeberger Harald, Hyvärinen Satu, Uzonyi Barbara, Szilágyi Ágnes, Prohászka Zoltán, Goldman Adrian, Józsi Mihály, Jokiranta T Sakari
From the Department of Bacteriology and Immunology, Medicum, and Immunobiology Research Program Unit, University of Helsinki and Helsinki University Hospital, 00014 University of Helsinki, Finland, the Institute of Biotechnology and
the Junior Research Group for Cellular Immunobiology, Leibniz Institute for Natural Product, Research and Infection Biology-Hans Knöll Institute, 07745 Jena, Germany.
J Biol Chem. 2015 Apr 10;290(15):9500-10. doi: 10.1074/jbc.M114.630871. Epub 2015 Feb 6.
Atypical hemolytic uremic syndrome (aHUS) is characterized by complement attack against host cells due to mutations in complement proteins or autoantibodies against complement factor H (CFH). It is unknown why nearly all patients with autoimmune aHUS lack CFHR1 (CFH-related protein-1). These patients have autoantibodies against CFH domains 19 and 20 (CFH19-20), which are nearly identical to CFHR1 domains 4 and 5 (CFHR14-5). Here, binding site mapping of autoantibodies from 17 patients using mutant CFH19-20 constructs revealed an autoantibody epitope cluster within a loop on domain 20, next to the two buried residues that are different in CFH19-20 and CFHR14-5. The crystal structure of CFHR14-5 revealed a difference in conformation of the autoantigenic loop in the C-terminal domains of CFH and CFHR1, explaining the variation in binding of autoantibodies from some aHUS patients to CFH19-20 and CFHR14-5. The autoantigenic loop on CFH seems to be generally flexible, as its conformation in previously published structures of CFH19-20 bound to the microbial protein OspE and a sialic acid glycan is somewhat altered. Cumulatively, our data suggest that association of CFHR1 deficiency with autoimmune aHUS could be due to the structural difference between CFHR1 and the autoantigenic CFH epitope, suggesting a novel explanation for CFHR1 deficiency in the pathogenesis of autoimmune aHUS.
非典型溶血性尿毒症综合征(aHUS)的特征是由于补体蛋白突变或针对补体因子H(CFH)的自身抗体导致补体攻击宿主细胞。目前尚不清楚为什么几乎所有自身免疫性aHUS患者都缺乏CFHR1(CFH相关蛋白-1)。这些患者具有针对CFH第19和20结构域(CFH19-20)的自身抗体,它们与CFHR1第4和5结构域(CFHR14-5)几乎相同。在这里,使用突变型CFH19-20构建体对17名患者的自身抗体进行结合位点图谱分析,发现第20结构域上一个环内的自身抗体表位簇,紧邻CFH19-20和CFHR14-5中不同的两个埋藏残基。CFHR14-5的晶体结构揭示了CFH和CFHR1 C端结构域中自身抗原环构象的差异,解释了一些aHUS患者自身抗体与CFH19-20和CFHR14-5结合的差异。CFH上的自身抗原环似乎通常是灵活的,因为它在先前发表的与微生物蛋白OspE和唾液酸聚糖结合的CFH19-20结构中的构象有所改变。累积来看,我们的数据表明CFHR1缺乏与自身免疫性aHUS的关联可能是由于CFHR1与自身抗原性CFH表位之间的结构差异,这为自身免疫性aHUS发病机制中CFHR1缺乏提供了一种新的解释。